Gelteq is trading at $0.54, down 10.33%, as higher Treasury yields pressured risk-sensitive equities overnight.
- U.S. stocks sold off on September 23, 2026, after stronger-than-expected business activity pushed the 10-year Treasury yield to its highest level since 2007.
- No new Gelteq-specific announcement appears on the company’s September 24 press-release page.
- Biotech’s broader pre-market strength suggests the decline is primarily macro-driven.